SFRS15 Inhibitors

SFRS15 inhibitors are a class of chemical compounds designed to selectively target and inhibit the activity of the SFRS15 protein, a member of the serine/arginine-rich splicing factor family. SFRS15 plays a key role in regulating alternative splicing, a critical cellular mechanism by which precursor messenger RNA (pre-mRNA) is processed into mature mRNA variants, ultimately producing different protein isoforms from a single gene. SFRS15 is involved in the recognition of specific splice sites and the orchestration of spliceosome assembly, influencing the splicing decisions of numerous genes. Inhibition of SFRS15 disrupts its function in splicing regulation, potentially altering the expression of various proteins by modifying how pre-mRNAs are spliced. This, in turn, can affect a range of cellular processes tied to the production of specific protein isoforms critical for cellular function and development.

The design of SFRS15 inhibitors focuses on creating compounds that can bind selectively to the unique structural regions of the SFRS15 protein. These inhibitors commonly interact with the RNA recognition motifs (RRMs) or the serine/arginine-rich (RS) domains, which are critical for the protein's role in binding RNA and regulating splice site selection. Structural studies of SFRS15 provide insights into these key regions, allowing for the rational design of inhibitors with high specificity and binding affinity. Researchers aim to craft molecules that selectively block SFRS15 activity without affecting other members of the serine/arginine-rich protein family, many of which have overlapping functions in splicing regulation. SFRS15 inhibitors are essential tools for investigating the intricate processes of splicing regulation and understanding how alternative splicing shapes the transcriptome, contributing to the diversity of protein expression in cells.